Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Fungal heat-shock proteins in human disease.

Burnie JP, Carter TL, Hodgetts SJ, Matthews RC.

FEMS Microbiol Rev. 2006 Jan;30(1):53-88. Review.

2.

Differential growth of epidemic methicillin-resistant Staphylococcus aureus in vancomycin.

Alshami I, Matthews RC, Burnie JF, Asghar AH, Momenah AM.

Br J Biomed Sci. 2005;62(3):109-13.

PMID:
16196455
3.

Human recombinant antibody to HSP90: a natural partner in combination therapy.

Matthews RC, Burnie JP.

Curr Mol Med. 2005 Jun;5(4):403-11. Review.

PMID:
15977996
4.
5.

Recombinant antibodies: a natural partner in combinatorial antifungal therapy.

Matthews RC, Burnie JP.

Vaccine. 2004 Feb 17;22(7):865-71. Review.

PMID:
15040939
6.

Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90.

Matthews RC, Rigg G, Hodgetts S, Carter T, Chapman C, Gregory C, Illidge C, Burnie J.

Antimicrob Agents Chemother. 2003 Jul;47(7):2208-16.

7.

Surveillance of whooping cough should continue.

Matthews RC, Preston NW, Holden DJ.

BMJ. 2002 Oct 19;325(7369):904. No abstract available.

8.

Identification of an immunodominant drug efflux pump in Burkholderia cepacia.

Wigfield SM, Rigg GP, Kavari M, Webb AK, Matthews RC, Burnie JP.

J Antimicrob Chemother. 2002 Apr;49(4):619-24.

PMID:
11909835
9.
10.

The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections.

Polonelli L, Casadevall A, Han Y, Bernardis F, Kirkland TN, Matthews RC, Adriani D, Boccanera M, Burnie JP, Cassone A, Conti S, Cutler JE, Frazzi R, Gregory C, Hodgetts S, Illidge C, Magliani W, Rigg G, Santoni G.

Med Mycol. 2000;38 Suppl 1:281-92. Review.

PMID:
11204156
11.

Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections.

Burnie JP, Matthews RC, Carter T, Beaulieu E, Donohoe M, Chapman C, Williamson P, Hodgetts SJ.

Infect Immun. 2000 Jun;68(6):3200-9.

12.

Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting.

Lamura L, Matthews RC, Barchiesi F, Donahoe M, Burnie JP, Scalise G.

J Infect. 2000 Jan;40(1):64-8.

PMID:
10762114
13.

Bordetella pertussis infection: pathogenesis, diagnosis, management, and the role of protective immunity.

Kerr JR, Matthews RC.

Eur J Clin Microbiol Infect Dis. 2000 Feb;19(2):77-88. Review.

PMID:
10746492
14.

Bordetella pertussis surveillance in England and Wales: 1995-7.

Van Buynder PG, Owen D, Vurdien JE, Andrews NJ, Matthews RC, Miller E.

Epidemiol Infect. 1999 Dec;123(3):403-11.

15.

The Bpel locus encodes type III secretion machinery in Bordetella pertussis.

Kerr JR, Rigg GP, Matthews RC, Burnie JP.

Microb Pathog. 1999 Dec;27(6):349-67.

PMID:
10588908
16.

Semiquantitative polymerase chain reaction enzyme immunoassay for the diagnosis of pertussis.

Matthews RC, Golbang N, Brück WM, Owen D, Bailey A, Weston V, Kerr JR.

Eur J Clin Microbiol Infect Dis. 1999 Oct;18(10):748-50.

PMID:
10584906
17.
18.

Stress proteins in fungal diseases.

Matthews RC, Maresca B, Burnie JP, Cardona A, Carratu L, Conti S, Deepe GS, Florez AM, Franceschelli S, Garcia E, Gargano LS, Kobayashi GS, McEwen JG, Ortiz BL, Oviedo AM, Polonelli L, Ponton J, Restrepos A, Storlazzi A.

Med Mycol. 1998;36 Suppl 1:45-51. Review.

PMID:
9988491
19.

Acellular pertussis vaccines: progress but déjà vu.

Preston NW, Matthews RC.

Lancet. 1998 Jun 13;351(9118):1811-2. No abstract available.

PMID:
9635974
20.

The renaissance of antibody therapy.

Burnie JP, Matthews RC.

J Antimicrob Chemother. 1998 Mar;41(3):319-22. Review. No abstract available.

PMID:
9578156
21.

Epitope mapping Candida albicans proteinase (SAP 2).

Ghadjari A, Matthews RC, Burnie JP.

FEMS Immunol Med Microbiol. 1997 Oct;19(2):115-23.

22.
23.

Semiquantitative polymerase chain reaction enzyme immunoassay for diagnosis of disseminated candidiasis.

Burnie JP, Golbang N, Matthews RC.

Eur J Clin Microbiol Infect Dis. 1997 May;16(5):346-50.

PMID:
9228473
24.

Toxoid vaccine for pertussis.

Preston NW, Matthews RC.

Lancet. 1997 Jan 11;349(9045):137; author reply 137-8. No abstract available.

PMID:
8996452
25.

The effect of an accelerated immunisation schedule on pertussis in England and Wales.

White JM, Fairley CK, Owen D, Matthews RC, Miller E.

Commun Dis Rep CDR Rev. 1996 May 24;6(6):R86-91.

PMID:
8664929
26.

Defining antibody targets in Streptococcus oralis infection.

Burnie JP, Brooks W, Donohoe M, Hodgetts S, al-Ghamdi A, Matthews RC.

Infect Immun. 1996 May;64(5):1600-8.

27.

Components of acellular pertussis vaccines.

Preston NW, Matthews RC.

Lancet. 1996 Mar 16;347(9003):764. No abstract available.

PMID:
8602023
28.

Transmission of pertussis: do adults have an important role?

Preston NW, Matthews RC.

Lancet. 1996 Jan 13;347(8994):129-30. No abstract available.

PMID:
8538333
29.

Comparative assessment of the detection of candidal antigens as a diagnostic tool.

Matthews RC.

J Med Vet Mycol. 1996 Jan-Feb;34(1):1-10. Review. No abstract available.

PMID:
8786465
30.

Application of pulsed field gel electrophoresis to the 1993 epidemic of whooping cough in the UK.

Syedabubakar SN, Matthews RC, Preston NW, Owen D, Hillier V.

Epidemiol Infect. 1995 Aug;115(1):101-13.

31.

Immunological and bacteriological distinction between parapertussis and pertussis.

Preston NW, Matthews RC.

Lancet. 1995 Feb 18;345(8947):463-4. No abstract available.

PMID:
7853990
32.

Defining potential targets for immunotherapy in Burkholderia cepacia infection.

Burnie JP, al-Wardi EJ, Williamson P, Matthews RC, Webb K, David T.

FEMS Immunol Med Microbiol. 1995 Jan;10(2):157-64.

PMID:
7536517
33.

Pathogenicity determinants of Candida albicans: potential targets for immunotherapy?

Matthews RC.

Microbiology. 1994 Jul;140 ( Pt 7):1505-11. Review. No abstract available.

PMID:
8075793
34.

Human recombinant antibodies and immunotherapy.

Matthews RC, Burnie JP.

FEMS Immunol Med Microbiol. 1994 Jun;9(1):1-6. Review. No abstract available.

PMID:
7920459
35.

Immunodiagnosis of invasive fungal infections.

De Repentigny L, Kaufman L, Cole GT, Kruse D, Latgé JP, Matthews RC.

J Med Vet Mycol. 1994;32 Suppl 1:239-52. Review. No abstract available.

PMID:
7722790
36.

Epitope mapping human heat shock protein 90 with sera from infected patients.

al-Dughaym AM, Matthews RC, Burnie JP.

FEMS Immunol Med Microbiol. 1994 Jan;8(1):43-8.

PMID:
7512400
37.

Characterization of outbreak and vaccine strains of Bordetella pertussis--Quebec.

Knowles K, Lorange M, Matthews RC, Preston NW.

Can Commun Dis Rep. 1993 Nov 15;19(21):182-3, 186-7. English, French. No abstract available.

PMID:
8298581
38.
39.
40.

PCR fingerprinting microbes by random amplification of polymorphic DNA.

Matthews RC.

J Med Microbiol. 1993 Sep;39(3):161-2. No abstract available.

PMID:
8366512
42.

Pertussis vaccination.

Matthews RC.

Lancet. 1993 Aug 21;342(8869):493. No abstract available.

PMID:
8102444
43.

Early diagnosis of systemic candidal infection.

Matthews RC.

J Antimicrob Chemother. 1993 Jun;31(6):809-12. Review. No abstract available.

PMID:
8360121
44.
45.

The abortion issue: a "battle worth fighting".

Matthews RC.

Tex Med. 1992 Oct;88(10):8. No abstract available.

PMID:
1462263
46.

67Ga-9N3 uptake by xenografts of human melanotic melanoma in mice.

Harrison A, Walker CA, Pereira KA, Parker D, Royle L, Matthews RC, Craig AS.

Nucl Med Commun. 1992 Sep;13(9):667-72.

PMID:
1448240
47.

Clamped homogeneous electric field gel electrophoresis typing of Torulopsis glabrata isolates causing nosocomial infections.

Khattak MN, Burnie JP, Matthews RC, Oppenheim BA.

J Clin Microbiol. 1992 Aug;30(8):2211-5.

48.

Clinical applications of molecular biology to diagnostic microbiology.

Matthews RC, Burnie JP.

J Clin Pathol. 1992 Jun;45(6):465-7. Review. No abstract available.

49.
50.

Restriction endonuclease analysis of Aspergillus fumigatus DNA.

Burnie JP, Coke A, Matthews RC.

J Clin Pathol. 1992 Apr;45(4):324-7.

Supplemental Content

Loading ...
Support Center